Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: Third Rock Raises $770m To Launch Up To 12 New Companies

Finance Watch

Related Content

IPO Update: Pace Of US Offerings Slows As 13 Biopharmas Go Public In 2019

May 01 2019

Myovant's Relugolix May Be Competitive With AbbVie Drug In Uterine Fibroids

May 14 2019

BIO-Europe Spring 2019: Themis Bioscience Harnesses Measles Vector For Immune Modulation

May 22 2019

Finance Watch: Q1 Numbers Suggest A Brisk VC Deal Pace For Cell And Gene Therapies In 2019

May 23 2019

Finance Watch: VC Mega-Deals Launch Biopharma Firms With New Takes On CV, Genetic Diseases

Mar 05 2019

Galderma’s First-In-Class Biologic Chases Eczema Spoils

Mar 12 2019

China's EpimAb Hunts For Novel Biologics With Funding, Partnerships

Jun 15 2017

China's EpimAb Advances Bispecific Antibody To Rival Janssen Candidate

Feb 12 2019

Deal Watch: Roivant Spins Out Arvelle, Licenses Epilepsy Candidate From SK Biopharma

Feb 15 2019

Interview: ViroMed On Pricing, Manufacturing World’s First Broadly Used Gene Therapy

Mar 01 2019

Ipsen Pays $575m Upfront For Struggling Pancreatic Drug Onivyde

Jan 10 2017

Finance Watch: BIO Report Shows Record VC Funding Across Geographies

Jun 04 2019

Deal Watch: Novartis Opts In On Lipoprotein A Candidate From Akcea

Feb 25 2019

Merrimack Pharma Cutting Jobs Again After Shelving Third Cancer Drug In Year

Apr 05 2019

Finance Watch: Arteaus Comes Full Circle As Investors Monetize Emgality Royalties

Apr 01 2019

Dsuvia Approval May Be Followed By New Opioid Review Paradigm At FDA

Nov 02 2018

Deal Watch: Allergan, Regeneron Both Look To Hydrogel Tech

Oct 14 2016

Finance Watch: Summer Slowdown Begins Ahead Of BIO, But Two IPOs Launched

Jun 19 2017

AbbVie Buys In On Morphic’s Oral Integrin Inhibitors, To Tune Of $100m

Oct 18 2018

Four Early-Stage Antibacterial Drugs To Watch: Highlights From IDWeek

Oct 09 2018

Amicus Makes Its Gene Therapy Move, Focusing On CNS Lysosomal Storage Disorders

Sep 20 2018

Finance Watch: Morphic's 'Smooth' Progress With Oral Integrin Inhibitors Justifies $80m Series B

Sep 26 2018

Finance Watch: Not Everyone Can Go Public, But Biopharma IPOs Are Using Multiple Markets

Nov 15 2018

Interview: PharmAbcine's Hopes Rise As Tanibirumab Set For Keytruda Combo Trials

Sep 03 2018

Takeda Alliance Boosts Liver Disease Venture Ambys’s $140m Launch

Aug 09 2018

Themis Bioscience Reaps Bill Gates' Backed CEPI Funding For Lassa Fever And MERS Vaccines

Mar 07 2018

ViroMed's Plasmid DNA Facility Buy Addresses Key Potential US Regulatory Hurdle

Jul 23 2018

Related Companies

Johns Hopkins University

Agios Pharmaceuticals, Inc.

Genetix Biotherapeutics

CytomX Therapeutics, Inc.

Editas Medicine

MyoKardia, Inc.

Sage Therapeutics, Inc.

Larimar Therapeutics, Inc.

Maze Therapeutics, Inc.

Takeda Pharmaceutical Co. Ltd.

Ambys Medicines

EpimAb Biotherapeutics, Inc.

Kymab Ltd.

Lung Therapeutics, Inc.

Arizona State University

Themis Bioscience GmbH

Inhibrx, Inc.

Karuna Therapeutics, Inc.

Morphic Therapeutic, Inc.

Johnson & Johnson

AbbVie Inc.

Kiadis Pharma N.V.

Amicus Therapeutics, Inc.

Additional Topics

Financing StartUps and SMEs Business Strategies Commercial BioPharmaceutical

More from Financing

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window